Article
Coherus BioSciences launches biosimilar version of AbbVie's blockbuster Humira
Rating:
0.0
Views:
62
Likes:
1
Library:
1
Coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United States at a discount of more than 85% to the blockbuster arthritis drug.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value